EMA — authorised 28 October 2010
- Marketing authorisation holder: Pharming Group N.V.
- Status: approved
EMA authorised Ruconest on 28 October 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 28 October 2010.
Pharming Group N.V. holds the EU marketing authorisation.